Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-09-20

Clinical Trial Update: Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers

View source ↗

Summary

Clinical trial update evaluating the safety and feasibility of using Epicall to monitor pre-seizure biomarkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epicall

Snippet

Sponsor: Epicall LTD | Conditions: Seizure | Status: UNKNOWN